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A Role for IL-15 in Driving the Onset of Spontaneous
Autoimmune Thyroiditis?1
Pete Kaiser,2* Lisa Rothwell,* Dusan Vasˇı´cˇek,3† and Karel Hala†
The obese strain (OS) of chickens, which suffers from spontaneous autoimmune thyroiditis, is an excellent animal model for
Hashimoto’s thyroiditis and provides a unique opportunity to investigate the mechanisms underlying and driving the onset of the
disease. Following recent advances in cloning chicken cytokines, we can now begin to investigate the role of cytokines in driving
the lymphoid infiltration of the thyroid seen in these birds from day 7 posthatch. Using real-time quantitative RT-PCR, we
characterized the expression of IFN-, IL-1, IL-2, IL-6, IL-8, IL-15, and IL-18 in thyroids from OS birds and control CB line
birds, both in the embryo just before hatch (embryonic day 20) and at 3 and 5 days posthatch. All of these cytokines were
up-regulated compared with levels in thyroids from CB birds, at least at some time points, with some evidence for coordination
of regulation, e.g., for the proinflammatory cytokines IL-1 and IL-8. Only IL-15 was up-regulated at all time points. IL-15 was
also shown to be up-regulated in spleens of OS birds at embryonic day 20 and 5 days posthatch, suggesting that IL-15 is
constitutively up-regulated in this line of birds. This could explain the general immune system hyperreactivity exhibited by OS
chickens and may be a factor driving the lymphoid infiltration of the thyroid. The Journal of Immunology, 2002, 168: 4216–4220.
H ashimoto’s thyroiditis is a human organ-specific autoim-mune disease that affects people of all ages, with peakoccurrence in women of 30–50 years of age (1). Chick-
ens of the obese strain (OS)4 with spontaneous autoimmune thy-
roiditis (SAT) have been used as an animal model for studies of
this disease for the last 40 years (2, 3). All chickens from this strain
develop symptoms of hypothyroidism due to SAT, and the im-
mune system has been shown to be involved in the development of
SAT. The onset of mononuclear cell infiltration of the thyroid in
OS chicks is from 7 days of age, the first cells forming the mul-
tifocal infiltrates in the thyroid gland being activated CD4, IL-
2R, TCR-1 T cells (4). By 1 or 2 mo of age, the thyroid
architecture is almost completely destroyed (5, 6). OS chickens
exhibit general immune system hyperreactivity, believed in part to
be due to intrinsic production of cytokines, perhaps IL-2 (7). Other
immunomodulating factors in OS chickens that may contribute to
SAT include premature emigration of Th cells from the thymus to
the periphery during ontogenesis (8), an imbalance between effec-
tor and suppressor cells (9), and a disturbed immune-endocrine
system interaction (6). Cytokines, in particular, probably have a
role in initiating and perpetuating the disease.
Recent progress in the cloning of avian cytokines has led to the
development of reagents with which to measure cytokine produc-
tion in response to infection in the chicken. This should allow a
greater insight into the mechanisms controlling the responses of
the chicken to disease, both infectious and autoimmune, at both a
cellular and molecular level. The avian orthologues of the Th1
cytokines IFN-, IL-2, and IL-18 recently have been cloned (10–
12), as have the proinflammatory cytokines IL-1 (13) and IL-6 (14);
IL-15 (accession no. AF152927), which is closely related to IL-2; and
the chemokine IL-8 (15, 16). The genomic sequences and gene
structure for IFN- (17), IL-2 (18), IL-18 (P. Kaiser, unpublished
data), IL-1 (P. Kaiser, unpublished data), IL-15 (P. Kaiser, unpub-
lished data), and IL-8 (19) have been fully determined. A partial
genomic sequence for IL-6 has also been isolated recently (P. Kaiser,
unpublished data). Gene structure information makes possible the
design of probes and primers to specifically quantify cytokine mRNA
levels using real-time quantitative RT-PCR.
We aimed to determine the levels of mRNA of these cytokines
in the thyroids of 20-day-old embryos, 3- and 5-day-old OS, and
unaffected CB birds to try to determine which cytokines, if any,
might be driving the initial lymphocyte infiltration of the thyroid
from 7 days of age in OS birds.
Materials and Methods
Experimental animals
OS leukosis-free chickens (5), bred as a closed flock homozygous for the
MHC haplotype B13, were maintained under standardized conventional
conditions (20) in the Central Laboratory Animal Facilities of the Medical
Faculty, University of Innsbruck. Chickens of the unrelated leukosis-free
inbred CB line (MHC haplotype B12) were used as a control line.
The designation of MHC haplotypes conforms to the nomenclature
adopted at the International Workshop of the Chicken MHC (21). For
details on the lines used, see the review by Hala and Plachy (22). To
eliminate breeding errors, the MHC status of all animals was serologically
determined.
Real-time quantitative RT-PCR
Cytokine mRNA levels in thyroids and spleens from OS and CB birds were
quantified using a method based on that of Kaiser et al. (23).
Total RNA was prepared from pooled thyroids and spleens of five birds
of each strain (OS and CB) at embryonic day 20 (E20), 3 days of age
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(thyroids only), and 5 days of age using Trizol reagent (Life Technologies,
Gaithersburg, MD) following the manufacturer’s instructions. Purified
RNA was stored at 70°C.
For both cytokine and 28S rRNA-specific amplification, primers and
probes were designed using the Primer Express software program (PE Ap-
plied Biosystems, Foster City, CA). Details of the probes and primers are
given in Table I. All cytokine probes were designed, from the sequence of
the relevant genes, to lie across intron:exon boundaries. Cytokine probes
were labeled with the fluorescent reporter dye 5-carboxyfluorescein at the
5 end and with the quencher N,N,N,N-tetramethyl-6-carboxyrhodamine
(TAMRA) at the 3 end. The 28S probe was labeled with the fluorescent
reporter dye VIC (PE Applied Biosystems) at the 5 end and with TAMRA
at the 3 end.
RT-PCR was performed using the TaqMan EZ RT-PCR kit (PE Applied
Biosystems). Amplification and detection of specific products were per-
formed using the ABI PRISM 7700 Sequence Detection System (PE Ap-
plied Biosystems) with the following cycle profile: one cycle of 50°C for
2 min, 96°C for 5 min, 60°C for 30 min, and 95°C for 5 min, and 40 cycles
of 94°C for 20 s, 59°C for 1 min.
Quantification was based on the increased fluorescence detected by the
ABI PRISM 7700 Sequence Detection System due to hydrolysis of the
target-specific probes by the 5 nuclease activity of the rTth DNA poly-
merase during PCR amplification. The passive reference dye 6-carboxy-x-
rhodamine, which is not involved in amplification, was used to correct for
fluorescent fluctuations, resulting from changes in the reaction conditions,
for normalization of the reporter signal. Results are expressed in terms of
the threshold cycle value (Ct ), the cycle at which the change in the reporter
dye passes a significance threshold. In this work, the threshold values of the
change in the reporter dye are as shown in Table II for all reactions
described.
To generate standard curves for the cytokine and 28S rRNA-specific
reactions, total RNA, extracted from appropriately stimulated lymphoid
cells, was serially diluted in sterile RNase-free water, and dilutions were
made from 101 to 105. Each RT-PCR experiment contained three no-
template controls, test samples, and a log10 dilution series. Each experi-
ment was performed in triplicate, with replicates performed on different
days. Regression analysis of the mean values of six replicate RT-PCRs for
the log10 diluted RNA was used to generate standard curves.
Results
Cytokine expression in the thyroid before the clinical onset
of SAT
Replicate measurements on different days were highly repeatable,
with a coefficient of variation for six replicate RT-PCRs of log10
serially diluted RNA for the different reactions, as shown in Table
II. There was a linear relationship between the amount of input
RNA and the Ct values for the various reactions as shown in Table
II. Regression analyses of the Ct values generated by the log10
dilution series gave R2 values for all reactions in excess of 0.98
(see Table II for details). The increase in cycles per log10 decrease
in input RNA for each specific reaction, as calculated from the
slope of the respective regression line, is given in Table II.
To control for variation in sampling and RNA preparation, the
Ct values for cytokine-specific product for each sample were stan-
dardized using the Ct value of 28S rRNA product for the same
sample. The Ct values for 28S rRNA did not alter significantly
from sample to sample; the average 28S rRNA Ct values for all
samples ranged from 9.12 to 10.46. Cytokine-specific Ct values
varied from sample to sample and from cytokine to cytokine. The
Ct values for 28S rRNA thus appeared to be independent of cyto-
kine production and disease. Therefore, they were taken to be rep-
resentative of the level of RNA extracted from all samples. To
normalize RNA levels between samples within an experiment, the
mean Ct value for 28S rRNA-specific product was calculated by
pooling values from all samples in that experiment. Tube-to-tube
variations in 28S rRNA Ct values about the experimental mean
Table I. Real-time quantitative RT-PCR probes and primersa
RNA Target Probe/Primer Sequence Exon Boundary Acc. No.
28S Probe 5-(VIC)-AGGACCGCTACGGACCTCCACCA-(TAMRA)-3 X59733
F 5-GGCGAAGCCAGAGGAAACT-3
R 5-GACGACCGATTTGCACGTC-3
IFN- Probe 5-(FAM)-TGGCCAAGCTCCCGATGAACGA-(TAMRA)-3 3/4 Y07922
F 5-GTGAAGAAGGTGAAAGATATCATGGA-3
R 5-GCTTTGCGCTGGATTCTCA-3
IL-1 Probe 5-(FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA)-3 5/6 AJ245728
F 5-GCTCTACATGTCGTGTGTGATGAG-3
R 5-TGTCGATGTCCCGCATGA-3
IL-2 Probe 5-(FAM)-ACTGAGACCCAGGAGTGCACCCAGC-(TAMRA)-3 2/3 AJ224516
F 5-TTGGAAAATATCAAGAACAAGATTCATC-3
R 5-TCCCAGGTAACACTGCAGAGTTT-3
IL-6 Probe 5-(FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-(TAMRA)-3 3/4 AJ250838
F 5-GCTCGCCGGCTTCGA-3
R 5-GGTAGGTCTGAAAGGCGAACAG-3
IL-8 Probe 5-(FAM)-TCTTTACCAGCGTCCTACCTTGCGACA-(TAMRA)-3 1/2 AJ009800
F 5-GCCCTCCTCCTGGTTTCA G-3
R 5-TGGCACCGCAGCTCATT-3
IL-15 Probe 5-(FAM)-AAGTTGCAAATCTTGCATTTCCATTTTTCCA-(TAMRA)-3 4/5 AJ416937
F 5-TAGGAAGCATGATGTACGGAACAT-3
R 5-TTTTTGCTGTTGTGGAATTCAACT-3
IL-18 Probe 5-(FAM)-CCGCGCCTTCAGCAGGGATG-(TAMRA)-3 4/5 AJ276026
F 5-AGGTGAAATCTGGCAGTGGAAT-3
R 5-ACCTGGACGCTGAATGCAA-3
a Acc. No., genomic DNA sequence; F, forward; R, reverse; FAM, 5-carboxyfluorescein.
Table II. Standard curve data from real-time quantitative RT-PCRs on
total RNA extracted from stimulated splenocytes
Rna Log Dilutions Ct R2 Slope
28S 0.05 101–105 8–22 0.9833 3.0005
IFN- 0.01 101–105 17–31 0.9899 3.289
IL-1 0.02 101–105 24–38 0.9856 3.1553
IL-2 0.02 101–105 26–38 0.9896 2.4279
IL-6 0.02 101–105 23–37 0.9992 3.2841
IL-8 0.02 101–105 14–27 0.9938 2.7728
IL-15 0.02 101–105 22–36 0.9952 2.8154
IL-18 0.02 101–105 17–33 0.9973 3.1123
a Rn, Change in the reporter dye; Ct, the cycle at which the change in the reporter
dye levels detected passes the Rn; R2, coefficient of regression.
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were calculated. The slope of the 28S rRNA log10 dilution series
regression line was used to calculate differences in input total
RNA. Using the slopes of the respective cytokine log10 dilution
series regression lines, the difference in input total RNA, as rep-
resented by the 28S rRNA, was then used to adjust cytokine-spe-
cific Ct values. Fig. 1 shows the effect of standardizing cytokine-
specific Ct values to correct for tube-to-tube variation in RNA
levels. Standardization does not dramatically alter the distribution
of the results as a whole.
IL-18 mRNA expression is up-regulated in OS E20 thyroids
compared with CB E20 thyroids (Fig. 2). At 3 and 5 days posthatch,
there is no difference in IL-18 mRNA expression between OS and
CB thyroids. IFN- mRNA is down-regulated in OS E20 thyroids
compared with CB E20 thyroids, it is of equal expression at 3 days
posthatch, and it is up-regulated by 5 days posthatch (Fig. 2).
Up-regulation of the expression of the proinflammatory cyto-
kines in OS thyroids compared with CB thyroids is biphasic (E20
and 5 days posthatch) for IL-1 and IL-8, and at 5 days posthatch
only for IL-6 (Fig. 3). At the other time points, there are no dif-
ferences in mRNA expression between OS and CB thyroids for
these cytokines, with the exception being IL-8 at 3 days posthatch,
which is down-regulated in thyroids from OS birds.
IL-2 mRNA expression is up-regulated in OS thyroids com-
pared with CB thyroids at 3 days posthatch only (Fig. 4). By
contrast, IL-15 mRNA expression is up-regulated in OS thyroids at
all time points in this study (Fig. 4).
FIGURE 1. Quantification of IL-18 mRNA in RNA extracted from
pooled thyroids from 20-day-old embryos and 3- and 5-day-old birds from
either OS or CB strains (five birds per line per time point). Ct are expressed
subtracted from 40 (the negative end point). Therefore, higher values rep-
resent higher levels of cytokine mRNA. , Cytokine mRNA-specific Ct
values before standardization for input RNA; f, standardized values for
cytokine mRNA corrected for variation in input RNA measured by 28S
rRNA levels.
FIGURE 2. Quantification of IL-18 and IFN- mRNA in RNA ex-
tracted from pooled thyroids from 20-day-old embryos and 3- and 5-day-
old birds from either OS or CB strains (five birds per line per time point),
corrected for variation in input RNA as measured by 28S rRNA levels. The
results are expressed as fold change in cytokine mRNA levels in pooled
thyroids from OS birds when compared with those from age-matched CB
birds (set as 1). No difference in mRNA levels, therefore, is shown as a fold
change of 1. Error bars show SEM for triplicate samples from three sep-
arate TaqMan experiments.
FIGURE 3. Quantification of proinflammatory cytokine mRNA (IL-1,
IL-6, and IL-8) in RNA extracted from pooled thyroids from 20-day-old
embryos and 3- and 5-day-old birds from either OS or CB strains (five
birds per line per time point), corrected for variation in input RNA as
measured by 28S rRNA levels. The results are expressed as fold change in
cytokine mRNA levels in pooled thyroids from OS birds when compared
with those from age-matched CB birds (set as 1). No difference in mRNA
levels, therefore, is shown as a fold change of 1. Error bars show SEM for
triplicate samples from three separate TaqMan experiments.
FIGURE 4. Quantification of IL-15 and IL-2 mRNA in RNA extracted
from pooled thyroids from 20-day-old embryos and 3- and 5-day-old birds
from either OS or CB strains (five birds per line per time point), corrected
for variation in input RNA as measured by 28S rRNA levels. The results
are expressed as fold change in cytokine mRNA levels in pooled thyroids
from OS birds when compared with those from age-matched CB birds (set
as 1). No difference in mRNA levels, therefore, is shown as a fold change
of 1. Error bars show SEM for triplicate samples from three separate Taq-
Man experiments.
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IL-15 mRNA expression is up-regulated in both spleens and
thyroids of OS birds, both in the embryo and posthatch,
compared with CB birds
Given the striking up-regulation of IL-15 mRNA in the thyroids of
OS chickens at all stages sampled in this study compared with
IL-15 mRNA levels in CB thyroids, we also investigated IL-15
mRNA expression in the spleens of E20 birds and birds 5 days
posthatch. IL-15 mRNA expression is up-regulated in both the
spleen and thyroid of OS birds at E20 and day 5 posthatch com-
pared with CB birds (Fig. 5).
Discussion
IFN- has been shown to be up-regulated in the thyroids of pa-
tients suffering from Hashimoto’s autoimmune thyroiditis (24–26)
and in chickens after the onset of lymphoid infiltration of the thy-
roid in OS birds suffering from SAT (27). We have shown that
IFN- expression in the embryonic thyroid before the onset of
SAT in OS birds is down-regulated compared with CB chickens
and that it is only up-regulated in the thyroid from OS birds 5 days
posthatch, i.e., 2 days before the onset of lymphoid infiltration of
the thyroid. In the thyroids of 5-day-old chicks, lymphocytes were
not detected by immunohistochemistry (5). At this age, the thyroid
mainly comprises cells of the thyroid follicular epithelium, fibro-
blasts, macrophages, and blood capillaries, none of which are able,
under physiological conditions, to produce IFN-. Transgenic
mice that constitutively express IFN- in the thyroid follicular
cells developed severe hypothyroidism (28). In our model, the in-
duction of expression of IFN- mRNA in the thyroid (Fig. 2), with
subsequent lymphocyte infiltration, may be the result of a cytokine
activation cascade initiated by IL-18 expression. This working
concept of the mechanisms underlying the breakdown of self-tol-
erance and the induction of autoimmunity requires additional
experiments.
IL-18 is not up-regulated in patients suffering from Hashimoto’s
thyroiditis (29), although such patients do have elevated IFN-
levels (see above). In mammals, IL-18 has three main roles: to
induce IFN- production (30), to enhance NK cell activity (31),
and to activate neutrophils (32). To date, chicken IL-18 has only
been shown to induce IFN- expression by splenocytes (12). It is
interesting to note that thyroids from E20 OS birds have elevated
IL-18 mRNA levels compared with age-matched thyroids from CB
birds, suggesting that this elevated IL-18, if resulting in bioactive
protein, might be driving the elevated IFN- levels seen later
in SAT.
Not surprisingly, considering the implication of T cell-mediated
cytotoxic processes in the pathogenesis of Hashimoto’s thyroiditis
after the lymphoid infiltration of the thyroid, the proinflammatory
cytokines IL-1, IL-6, and IL-8 have all been shown to be ex-
pressed in the thyroids of patients suffering from the disease (26,
33–36). This report shows that these cytokines are expressed in the
thyroids of OS chickens before the onset of the lymphoid infiltra-
tion. Interestingly, for two of these cytokines (IL-1 and IL-8) the
up-regulation of their mRNA is biphasic, occurring both in the
embryo (E20) and just before the onset of the lymphoid infiltration
associated with the disease (day 5 posthatch). IL-6, in contrast, is
only up-regulated 5 days posthatch.
IL-2 has been implicated in the pathogenesis of both Hashimo-
to’s thyroiditis (33, 37) and SAT (7, 38). However, IL-2 mRNA is
only up-regulated in the thyroids of OS birds at 3 days posthatch
and therefore seems an unlikely candidate to be driving the lym-
phoid infiltration of the thyroid seen from day 7 posthatch. By
contrast, the closely related cytokine IL-15 is up-regulated at all
points in this study. In mammals, IL-15 shares many of the bio-
logical properties of IL-2. As well as being up-regulated in the
thyroid of OS birds, IL-15 is also constitutively up-regulated in the
spleens of OS birds at E20 and day 5 posthatch. Therefore, IL-15
represents a good candidate for the general immune system hy-
perreactivity in OS birds (7) and may play a role in driving the
lymphoid infiltration of the thyroid (IL-15 can be chemotactic
for lymphocytes (39, 40)). There is one report of IL-15 mRNA
being up-regulated in the thyroids of Hashimoto’s thyroiditis
patients (41).
At present, a lack of IL-15-specific reagents prevents us from
investigating the role of this cytokine in SAT further. One obvious
candidate for the overexpression of IL-15 in OS chickens would be
a promoter polymorphism. However, although we have deter-
mined the gene structure for chicken IL-15, as yet we have no
information on the promoter of chicken IL-15. Although bioactive
recombinant chicken IL-15 has recently been expressed (42), as
yet there are no mAbs described for chicken IL-15. However,
mAbs specific for the -chain of the IL-15R recently have been
described (43), two of which inhibit the proliferative effect of
IL-15 on T cells. This raises the possibility of blocking experi-
ments in ovo and in vivo to determine whether IL-15 has a direct
role in driving SAT, although these are far from simple in avian
species because murine Abs do not fix chicken complement.
One potential drawback of real-time quantitative PCR is that, for
cytokines, mRNA does not necessarily equate to bioactive protein.
For example, both IL-1 and IL-18 in mammals are produced
initially as propeptides, which are then cleaved into an active form
by the action of caspase-1 (44–47). The same mechanism is
thought to apply for the avian orthologues of these two cytokines
(12, 13). IL-15 production in mammals, in contrast, is predomi-
nantly controlled posttranslationally, and mRNA levels may be
greater than protein levels (48–51). For other cytokines, mRNA
levels correlate extremely well with bioactive protein. For exam-
ple, in the chicken, IFN- and IL-6 mRNA levels (as measured by
real-time quantitative PCR) and protein levels (as measured by
bioassays) are in close agreement (23). However, we only have
reliable bioassays for a limited number of chicken cytokines (type
I IFN, IFN-, IL-1, IL-2, IL-6, and IL-18) and mAbs to even
fewer (type I IFN, IFN-, and IL-2). Overall, real-time quantitative
PCR is currently the only method that allows us to quantify a wide
variety of avian cytokines within a particular disease model.
The question remains as to which cells in the thyroid of OS birds
are expressing the cytokines we have identified in this study. To
FIGURE 5. Quantification of IL-15 mRNA in RNA extracted from
pooled spleens (S) and thyroids (T) from 20-day-old embryos and 5-day-
old birds from either OS or CB strains (five birds per line per time point),
corrected for variation in input RNA as measured by 28S rRNA levels. The
results are expressed as fold change in cytokine mRNA levels in pooled
thyroids from OS birds when compared with those from age-matched CB
birds (set as 1). Error bars show SEM for triplicate samples from three
separate TaqMan experiments.
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this end, we intend to develop in situ hybridization for chicken
cytokines in the thyroid, which in combination with immunohis-
tochemistry should enable us to determine the phenotype of the
cells expressing various cytokine mRNA before the onset of the
lymphoid infiltration.
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